Does it really matter if you win or lose the genetic lottery?
By Joseph L Graves Jr,
The Lancet
| 01. 01. 2022
Kathryn Paige Harden, Professor of Psychology who leads the Developmental Behavior Genetics lab at the University of Texas at Austin, USA, is considered by many in her field as an up and coming superstar. Her book, The Genetic Lottery: Why DNA Matters for Social Equality, proposes that an individual's genetic composition, specifically related to their capacity to succeed at education, has an important role in determining their social outcomes. Harden examines the role that an individual's genetic predisposition may have in contributing to their position in society.
To make her case, Harden relies on, for example, results of studies that have associated polygenic scores (PGS) with educational attainment. PGS are derived from genome-wide association studies and identify variants that are statistically associated with a given phenotype. Harden summarises results from a series of PGS studies that indicate that they predict educational attainment, and that educational attainment is associated with a number of social outcomes including greater wealth. None of this is particularly controversial to people who know genetics. The traits of all organisms, behavioural and otherwise, result from the complex...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...